$VRX upturn. now FDA $16.86
reverse head and
$VRX upturn. now FDA $16.86
reverse head and shoulders
candles at breakout
Website
Valeant Receives FDA Approval Of SILIQ(TM) (Brodalumab)
For Moderate-To-Severe Plaque Psoriasis CNW Group -
1 hour ago ago
Last ten trades
Stock Analylsis
Shares Outstanding 341.19M
Float 304.95M
% Held by Insiders 1.96%
% Held by Institutions 88.00%
Shares Short 35.6M
Short Ratio 2.39
Short % of Float 13.83%
Shares Short (prior month) 30.42M
News
and filings
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Xifaxan for the treatment of irritable bowel syndrome with diarrhea; Wellbutrin XL for major depressive disorder in adults; Solodyn to treat red and pus-filled pimples of acne in patients, as well as Ziana, Clindagel, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Glumetza to improve glycemic control in adults with type 2 diabetes mellitus; PROVENGE for the treatment of prostate cancer; and Jublia for onychomycosis of the toenails. It also provides Nitropress for the immediate reduction of blood pressure of patients in hypertensive crises; Isuprel for heart related treatments; Xenazine for chorea; Uceris to get ulcerative colitis under control; Lotemax gel for post-operative inflammation and pain; Arestin, a subgingival sustained-release antibiotic; PreserVision, an antioxidant eye vitamin and mineral supplement; CeraVe to rebuild and repair the skin barrier; Biotrue for healthy contact lens wear; and ReNu Multiplus to lubricate and rewet soft contact lenses. In addition, the company offers Ocuvite, a lutein eye vitamin and mineral supplement; Boston, a cleansing solution for gas permeable contact lenses; Artelac to treat dry eyes; various ophthalmic surgical products; SofLens daily disposable contact lenses; Biotrue ONEday lens; Bausch + Lomb Ultra, a contact lens PureVision, a contact lens; and medical device systems for aesthetic applications. Further, it provides Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; Metronidazole to treat bacterial infections; and Latanoprost for the treatment of glaucoma. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September, 2010. The company was founded in 1983 and is based in Laval, Canada
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
There's a badge of honor in the investment world that's not about the dollars and cents pouring in—it's about having founders trust you to take care of their business babies. Good Springs Capital just snagged one by being named to Inc.'s 2026 Founder-Friendly Investors list. Now, if you're thinking this is just some fancy accolade, let's chew over the real nuggets here....
Continue Reading
A Rough Road Ahead for Chemours Investors Well, folks, Chemours Company isn’t exactly living its best life right now. Following a tumble of 18.63% in its stock price after less-than-stellar second-quarter earnings, the legal hounds are circling the wagons. Investors who picked up shares between February 20, 2026, and August 4, 2026, might be feeling a bit sore right...
Continue Reading
The Thin Film Challenge: Decoding Dewetting Ah, dewetting—it's a bit like trying to keep a chocolate bar solid on a scorching summer day. These thin films, they're supposed to hold their own, spread thin and steady. But apply a little heat or a laser, and watch them form tiny islands, like a retreating tide. Now, there's some fresh thinking in the air, straight from...
Continue Reading
A Decade-Spanning Influence in Leadership After years of helping executives navigate the twists and turns of organizational life, Andrea P. Davis stands out as The Inner Circle's Pinnacle Professional of the Year. With over 25 years under her belt, Davis has tackled strategic planning, brand development, and organizational transformation like a prizefighter in the ring....
Continue Reading
There's something to be said for a game that sticks around for a full decade. Yeah, Hill Climb Racing 2 isn't just turning another year older—it's celebrating ten years on the scene, and Finnish developer Fingersoft is pulling out all the stops. Let's not mince words; keeping a mobile game alive and well-loved isn't easy, especially now when the app stores are packed...
Continue Reading
Enterprises on AI: From Dreams to Doing Alright, here’s a nugget for you: AI isn't just pie-in-the-sky jazz anymore. Some folks are finally bringing it down to Earth. Emergys, a player in digital transformation, is shaking hands with Glean, renowned for their enterprise AI chops, to turn enterprise chaos into clarity. It's all about squeezing out real returns and...
Continue Reading
Packing a Punch From Every Angle Listen, I've seen about every bag known to tech warriors, but WaterField's new Starlink Mini Go Case? It's turning some heads in the gizmo storage game. The folks at WaterField Designs, cooking out of San Francisco since '98, have whipped up something here that takes those clunky, military-style cases and swaps them for sleek, professional...
Continue Reading
MEDICA 2026: Wincomm and Portwell Join Forces November's got one heck of an event lined up with MEDICA 2026, where Wincomm and Portwell are teaming up to showcase what they've got up their sleeves in medical AI computing. This whole shebang runs from November 16 to 19, with their setup in Hall 12, Stand C76, Düsseldorf, Germany. But why should investors care? Because...
Continue Reading
Ever wonder where the cutting edge of military medicine takes shape? On February 16-17, 2027, Washington, DC becomes the epicenter for just that, as the Medical Technology Enterprise Consortium (MTEC) rolls out its 11th Annual Membership Meeting. A gathering of who's who in the world of military medical innovation, this event is like a high-stakes cocktail of science,...
Continue Reading
Scientific Games Breaks New Ground at WLS 2026 Innovation isn't about resting on your laurels, and boy, does Scientific Games know it. At the World Lottery Summit in Sydney this November, they're showcasing a buffet of cutting-edge games and technology aimed at revolutionizing the lottery landscape. But hey, this ain't just about flashy lights and digital frills –...
Continue Reading
Top 5 Most Recently Viewed Articles
BARE International Reports on Dynamic Growth and Client Success BARE International marked a significant milestone during its recent annual company update. The meeting highlighted the company’s impressive achievements, underscoring its expanded presence in multiple industries and regions. The outstanding results reflect a collective dedication to core values, innovative...
Continue Reading
Taiwan Stock Market Overview In recent trading sessions, Taiwan's stock market has experienced notable fluctuations. With various sectors contributing to the movements, the overall sentiment has been cautious as investors analyze market conditions and sector performances. A significant decline was observed as the trading day unfolded, particularly affecting the Taiwan...
Continue Reading
Recognizing Leadership in Public Service Recently, Governor JB Pritzker was honored with the prestigious Paul Simon Courage in Public Service Award by Lutheran Social Services of Illinois (LSSI) and Lutherans Unite for Illinois. This award celebrates individuals who embody the spirit of compassionate public policy, continuing the legacy of the late Senator Paul Simon. A...
Continue Reading
Overview of Recent FDA Announcements The U.S. Food and Drug Administration (FDA) has been making waves with some significant updates aimed at enhancing safety and effectiveness within numerous health sectors. These developments come from various branches of the agency, reflecting a commitment to improving public health through the regulation of food, drugs, and medical...
Continue Reading
MidWestOne Financial Group Announces Conference Call for Q3 2025 Earnings MidWestOne Financial Group, Inc. (NASDAQ: MOFG), the parent company of MidWestOne Bank, has exciting news for its investors as it prepares to announce its financial results for the third quarter of 2025. The results will be shared following the market's close on Thursday. Investors should note the...
Continue Reading